Platelet Endothelial Aggregation Receptor 1 (PEAR1), a Novel Epidermal Growth Factor Repeat-containing Transmembrane Receptor, Participates in Platelet Contact-induced Activation-Reference-Cited by-同舟云学术

Platelet Endothelial Aggregation Receptor 1 (PEAR1), a Novel Epidermal Growth Factor Repeat-containing Transmembrane Receptor, Participates in Platelet Contact-induced Activation

Published:2005-07 Issue:26 Volume:280 Page:24680-24689
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Nanda Nisha,Bao Ming,Lin Hanna,Clauser Karl,Komuves Laszlo,Quertermous Thomas,Conley Pamela B.,Phillips David R.,Hart Matthew J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference27 articles.

1. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function

2. CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism

3. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

4. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred

5. Contact-dependent signaling during the late events of platelet activation

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LOXL2-induced PEAR1 Ser891 phosphorylation suppresses CD44 degradation and promotes triple-negative breast cancer metastasis;Journal of Clinical Investigation;2024-08-15

2. Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study;Blood Advances;2024-07-24

3. Genetic factors related to aspirin resistance using the Multiplate® device in Hong Kong Chinese patients with stable coronary heart disease;Heliyon;2024-07

4. Molecular characterization of positively selected genes contributing aquatic adaptation in marine mammals;Genes & Genomics;2024-05-11

5. Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk;Clinical Cancer Research;2024-03-06